PALI
Palisade Bio Inc

19,216
Loading...
Loading...
News
all
press releases
Palisade Bio Announces 1-for-15 Reverse Stock Split
Carlsbad,CA, April 03, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), ( Palisade , Palisade Bio or the Company ), a biopharmaceutical company focused on developing and...
Globe Newswire·1y ago
News Placeholder
More News
News Placeholder
Palisade Bio files to sell 3.63M shares of common stock for holders
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago
News Placeholder
Analysts Are Bullish on Top Healthcare Stocks: Inventiva (IVA), Palisade Bio (PALI)
Theres a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Inventiva (IVA Research Report) and Palisade Bio...
TipRanks Financial Blog·1y ago
News Placeholder
Palisade Bio Reports Year End 2023 Financial Results and Provides Corporate Update
Rapid advancement of PALI-2108 towards Phase 1 clinical study for the treatment of moderate-to-severe ulcerative colitis; On track to commence Phase 1 before year end Formation of Clinical...
Globe Newswire·1y ago
News Placeholder
Palisade Bio to Present at Digestive Disease Week (DDW) 2024
Carlsbad,CA, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) ( Palisade or the Company ), a biopharmaceutical company focused on developing novel therapeutics for...
Globe Newswire·2y ago
News Placeholder
Palisade Bio's Corporate Shake-Up Sparks Investor Interest
Palisade Bio (PALI) has released an update. Dive into the latest buzz from the financial world as a renowned company unveils a corporate update tha...
TipRanks Financial Blog·2y ago
News Placeholder
Palisade Bio Provides Corporate Update and Reiterates Guidance
Company announces strategic streamlining of Board to align with the current state of clinical development and corporate vision Advancement of PALI-2108 for the treatment of moderate-to-severe...
Globe Newswire·2y ago
News Placeholder
Correction Notice of Palisade Bio's Press Release Announcing the Appointment of Clinical Advisory Board Members
Carlsbad,CA, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) ( Palisade or the Company ), a biopharmaceutical company focused on developing novel therapeutics for...
Globe Newswire·2y ago
News Placeholder
Palisade Bio Announces Formation of Clinical Advisory Board with Appointments of Preeminent Key Opinion Leaders
Palisade Bio, Inc. Bruce Sands MD, MS Palisade Bio, Inc. Florian Rieder, MD Bruce Sands, MD, MS., Dr. Burrill B. Crohn Professor of Medicine, Icahn School...
Globe Newswire·2y ago
News Placeholder
Palisade Bio exercises previously issued warrants fo $2.5M
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago

Latest PALI News

View

Advertisement. Remove ads.

Advertisement. Remove ads.